Drugs / lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells
lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00569985 | Jun 2007 → Nov 2019 | lymphoma | City of Hope Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00569985 ↗ |
| Modality | Cell therapy | “lentivirus-transduced hematopoietic progenitor cells (HPCs)” NCT00569985 ↗ |
| Route | Intravenous | “lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells and non-bound CD34+ cells IV on day 0” NCT00569985 ↗ |